Linda Gellatly
Adult Health · Lakeland, FLNPI 1366789109
Payments from drug & device makers
Across 106 payments — averaging $21.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$897
- Viiv Healthcare Company$701
- AbbVie$169
- Exact Sciences$126
- Merck$76
- Dexcom, Inc.$67
- plus $295 from 12 others
What the payments were for
- Food & beverage$2,31699%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 36 | $897 |
| Viiv Healthcare Company | 38 | $701 |
| AbbVie | 5 | $169 |
| Exact Sciences | 5 | $126 |
| Merck | 4 | $76 |
| Dexcom, Inc. | 3 | $67 |
| Lilly USA, LLC | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 1 | $31 |
| Amgen | 2 | $29 |
| Philips North America LLC | 2 | $28 |
| Indivior Inc. | 1 | $28 |
| Vertex | 1 | $25 |
| Alkermes, Inc. | 1 | $24 |
| Braeburn Inc. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DOVATO$125
How this compares
$2,330 in reported general payments places this provider in the 75th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 244 | $934,389 |
| EpclusaSofosbuvir/Velpatasvir | 15 | $374,018 |
| TivicayDolutegravir Sodium | 50 | $111,631 |
| PrezcobixDarunavir/Cobicistat | 35 | $85,745 |
| JulucaDolutegravir/Rilpivirine | 25 | $85,497 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 17 | $77,621 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 16 | $62,376 |
| DovatoDolutegravir Sodium/Lamivudine | 14 | $40,525 |
| CreonLipase/Protease/Amylase | 13 | $38,804 |
| PifeltroDoravirine | 12 | $21,091 |
| Darunavir | 16 | $8,709 |
| Ketoconazole | 21 | $670 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $549 |
| Ipratropium Bromide | 17 | $336 |
| Metoprolol Succinate | 21 | $272 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Epclusa, Genvoya | $897 | $1,370,784275 claims |
| Viiv Healthcare CompanyTivicay, Juluca, Dovato | $701 | $237,65489 claims |
| AbbVieCreon | $169 | $38,80413 claims |
| MerckPifeltro | $76 | $21,09112 claims |
| Lilly USA, LLCOlanzapine | $36 | $9411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,237 adult health providers in Florida.
Other adult health in Lakeland
- Ashley NewmanLakeland$23K
- Ana SierraLakeland$13K
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.